Advertising in medical journals: Should current practices change?
2006

Advertising in Medical Journals: Should Current Practices Change?

publication Evidence: high

Author Information

Author(s): Adriane Fugh-Berman, Karen Alladin, Jarva Chow

Primary Institution: Georgetown University School of Medicine

Hypothesis

Why do medical journals predominantly feature advertisements for drugs over other products?

Conclusion

Medical journals' reliance on pharmaceutical advertising compromises their objectivity and credibility.

Supporting Evidence

  • Pharmaceutical companies spent US$448 million on advertising in medical journals in 2003.
  • More than 95% of advertisements in JAMA were for pharmaceutical products.
  • Drug advertisements are not required to demonstrate product superiority before being accepted.

Takeaway

This study looks at how medical journals mostly show ads for drugs, which can make doctors think they need to prescribe those drugs, even if there are cheaper or better options.

Methodology

The authors surveyed advertising policies of nine major medical journals and analyzed the types of advertisements published.

Potential Biases

The dependence on pharmaceutical advertising may lead to conflicts of interest and influence editorial decisions.

Limitations

The study primarily focuses on advertising practices and does not assess the impact on prescribing behavior directly.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030130

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication